lunes, 29 de abril de 2024

Novel Incretin-Based Dual/Triple Agonists: The Future in Diabetes Care?

https://www.medscape.org/viewarticle/1000462_sidebar5?sso=true&uac=148436CN&ecd=mkm_ret_240429_mscpmrk-ES_CME_etid6461961&impID=6461961

No hay comentarios:

Publicar un comentario